Back to Search
DEBRA ROYCE, MD
MD
Family Medicine Physician
NPI: 1982706438Individual
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
R9J86(MO)
Research & Publications (13)
Synthetic triterpenoids attenuate cytotoxic retinal injury: cross-talk between Nrf2 and PI3K/AKT signaling through inhibition of the lipid phosphatase PTEN.
PMID 19494206·Invest Ophthalmol Vis Sci·2009
7-preclinical
Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription.
PMID 19484125·PLoS One·2009
7-preclinical
A novel acetylenic tricyclic bis-(cyano enone) potently induces phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by aflatoxin.
PMID 18701497·Cancer Res·2008
7-preclinical
Prevention and treatment of experimental estrogen receptor-negative mammary carcinogenesis by the synthetic triterpenoid CDDO-methyl Ester and the rexinoid LG100268.
PMID 18628471·Clin Cancer Res·2008
7-preclinical
The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis.
PMID 18483313·Mol Cancer Ther·2008
7-preclinical
A new rexinoid, NRX194204, prevents carcinogenesis in both the lung and mammary gland.
PMID 17947492·Clin Cancer Res·2007
7-preclinical
Novel semisynthetic analogues of betulinic acid with diverse cytoprotective, antiproliferative, and proapoptotic activities.
PMID 17620440·Mol Cancer Ther·2007
7-preclinical
The synthetic triterpenoids CDDO-methyl ester and CDDO-ethyl amide prevent lung cancer induced by vinyl carbamate in A/J mice.
PMID 17363558·Cancer Res·2007
7-preclinical
The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancer.
PMID 17020999·Clin Cancer Res·2006
4-observational
Design, synthesis, and anti-inflammatory activity both in vitro and in vivo of new betulinic acid analogues having an enone functionality in ring A.
PMID 16996735·Bioorg Med Chem Lett·2006
7-preclinical
The synthetic triterpenoid CDDO-Imidazolide suppresses STAT phosphorylation and induces apoptosis in myeloma and lung cancer cells.
PMID 16857804·Clin Cancer Res·2006
8-other
The synthetic triterpenoids, CDDO and CDDO-imidazolide, are potent inducers of heme oxygenase-1 and Nrf2/ARE signaling.
PMID 15930299·Cancer Res·2005
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1407 MINER ST
SARCOXIE, MO 64862 - Phone
- (417) 548-3334
Quick Facts
- NPI
- 1982706438
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 13
Are you this provider?
Claim Your Profile